Successful Treatment of a Child with Hemoglobin Hammersmith with Hematopoietic Stem Cell Transplantation

References

• Hung CC, Chien SC, Su YN, et al. Denaturing high-performance liquid chromatography: an efficient screening approach in the genetic diagnosis of Hemoglobin Hammersmith. Biomed Eng Appl Basis Common. 2006;18(06):343–347.
   Web of Science ®Google Scholar
• Dacie JV, Shinton NK, Gaffney PJ, Jr, et al. Haemoglobin Hammersmith (beta-42 (CDI) Phe replaced by ser). Nature. 1967;216(5116):663–665. doi: 10.1038/216663a0.
   PubMed Web of Science ®Google Scholar
• Shinton NK, Williams HP, Thursby-Pelham DC. Congenital Heinz-body haemolytic anaemia due to haemoglobin Hammersmith. Postgrad Med J. 1969;45(527):629–632. doi: 10.1136/pgmj.45.527.629.
   PubMed Web of Science ®Google Scholar
• Wajcman H, Leroux A, Labie D. Functional properties of hemoglobin Hammersmith. Biochimie. 1973;55(2):119–126. doi: 10.1016/s0300-9084(73)80383-9.
   PubMed Web of Science ®Google Scholar
• Ohba Y, Miyaji T, Matsuoka M, et al. Hemoglobin Chiba: Hb Hammersmith in a Japanese girl. Nihon Ketsueki Gakkai Zasshi. 1975;38(1):53–58.
   PubMedGoogle Scholar
• Rahbar S, Feagler RJ, Beutler E. Hemoglobin Hammersmith (beta 42 (CD1) Phe replaced by Ser) associated with severe hemolytic anemia. Hemoglobin. 1981;5(1):97–105. doi: 10.3109/03630268108996914.
   PubMed Web of Science ®Google Scholar
• Schroeder WA, Shelton JB, Shelton JR, et al. Identification of eleven human hemoglobin variants by high-performance liquid chromatography: additional data on functional properties and clinical expression. Biochem Genet. 1982;20(1–2):133–152. doi: 10.1007/BF00484942.
   PubMed Web of Science ®Google Scholar
• Rahbar S, Bennetts GA, Ettinger LJ. Hemoglobin Hammersmith as the cause of severe hemolytic anemia in a Chinese girl. Am J Pediatr Hematol Oncol. 1986;8(1):13–17. doi: 10.1097/00043426-198608010-00004.
   PubMedGoogle Scholar
• Dianzani I, Ramus S, Cotton RG, et al. A spontaneous mutation causing unstable Hb Hammersmith: detection of the beta 42 TTT-> TCT change by CCM and direct sequencing. Br J Haematol. 1991;79(1):127–129. doi: 10.1111/j.1365-2141.1991.tb08026.x.
   PubMed Web of Science ®Google Scholar
• Cunningham TA, Baker F, Kobrinsky NL, et al. The unstable Hb Hammersmith or alpha 2 beta 2(42)(CD1)Phe->Ser observed in an Indian child; identification by HPLC and by sequence analysis ofamplified DNA. Hemoglobin. 1992;16(1–2):19–25. doi: 10.3109/03630269209005672.
   PubMed Web of Science ®Google Scholar
• Tuohy AM, McKie VC, Sabio H, et al. Hb Hammersmith [beta 42(CD1) Phe-> Ser]: occurrence as a de novo mutation in black monozygotic twins with multiple congenital anomalies. J Pediatr Hematol Oncol. 1998;20(6):563–566. doi: 10.1097/00043426-199811000-00011.
   PubMed Web of Science ®Google Scholar
• Akiyama M, Murayama S, Yokoi K, et al. Hemoglobin Hammersmith [beta 42(CD1) Phe –>Ser] causing severe hemolytic anemia in a Japanese girl. Pediatr Blood Cancer. 2006;47(6):839–841. doi: 10.1002/pbc.20533.
   PubMed Web of Science ®Google Scholar
• Sonati MF, Kimura EM, Abreu CF, et al. Hemoglobin Hammersmith [beta42 (CD1) Phe –>Ser] in a Brazilian girl with congenital Heinz body hemolytic anemia. Pediatr Blood Cancer. 2006;47(6):855–856. doi: 10.1002/pbc.20851.
   PubMed Web of Science ®Google Scholar
• Eberle SJE, Noguera N, Calvo K, et al. Severe hemolytic anemia due to hemoglobin Hammersmith. Arch Argent Pediatr. 2009;107(4):347–349.
   PubMed Web of Science ®Google Scholar
• Park S, Kang HJ, Cho SI, et al. A case report of a male patient with Hb Hammersmith [β42(CD1)Phe→Ser, TTT>TCT]. Hemoglobin. 2012;36(2):161–165. doi: 10.3109/03630269.2011.645179.
   PubMed Web of Science ®Google Scholar
• Li R, Wang T, Xie XM, et al. Case report: prenatal diagnosis of Hb Hammersmith [β42 (CD1) Phe→ Ser; HBB: c. 128T>C] in a family with an adult male patient. Hemoglobin. 2014;38(2):142–145. doi: 10.3109/03630269.2014.880352.
   PubMed Web of Science ®Google Scholar
• Srewaradachpisal K, Tepakhan W, Kanjanaopas S, et al. Rare β-globin gene mutations including a de novo mutation of hemoglobin hammersmith in Southern Thailand. J Health Sci Med Res. 2020;38(3):221–229. doi: 10.31584/jhsmr.2020741.
   Google Scholar
• Pesce MM, Atkinson MM, Sridhar V, et al. Consideration of splenectomy in unstable hemoglobinopathy: a case report of Hb hammersmith (HBB: c. 128T>C). Hemoglobin. 2022; 46(4):197–200. doi: 10.1080/03630269.2022.2072318.
   PubMed Web of Science ®Google Scholar
• Chan WY, Chan NC, So JC, et al. Successful haploidentical hematopoietic stem cell transplantation (HSCT) and durable engraftment by repeated donor lymphocyte infusions for a Chinese patient with transfusion‐dependent hemoglobin (Hb) Hammersmith and massive splenomegaly. Pediatr Transplant. 2022;26(5):e14278.   doi: 10.1111/petr.14278.
   PubMed Web of Science ®Google Scholar
• Eduardo GFO, Valentina MRS, Camila GAM. Hemoglobin hammersmith associated with hemolytic anemia in a 3-year-old Colombian girl. GSC Biol Pharmaceut Sci. 2020;11(1):185–190.
   Google Scholar
• Lang SA, Chang PC, Laxdal VA, et al. Haemoglobin hammersmith precludes monitoring with conventional pulse oximetry. Can J Anaesth. 1994; 41(10):965–968. doi: 10.1007/BF03010939.
   PubMed Web of Science ®Google Scholar
• Wu SY, Keung YK, Hu E. Hemoglobin hammersmith as a cause of spurious pulse oximetry measurements proceedings of UCLA health. 2019. p. 23.
   Google Scholar
• Ramprakash S, Raghuram C, Marwah P, et al. Splenomegaly may increase the risk of rejection in low-risk matched related donor transplant for thalassemia, this risk can be partially overcome by additional immunosuppression during conditioning. Biol Blood Marrow Transplant. 2020;26(10):1886–1893. doi: 10.1016/j.bbmt.2020.06.013.
   PubMed Web of Science ®Google Scholar